The human T-lymphotropic virus type-1 (HTLV-1) was the first human retrovirus discovered 1 . It causes a highly aggressive T-cell malignancy named adult T-cell leukemia/ lymphoma (ATLL) and a severe chronic neurological disease called HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) 2 . Approximately 20 million people are infected with HTLV-1 worldwide. The endemic areas include tropical zones such as the Caribbean, Equatorial Africa, the Seychelles, Central and South America, and Temperate Zone, especially Southern Japan 3 . In Brazil, one of the highest prevalence is found in Salvador -Bahia with 1.76% of the population infected 4 . Investigators have described a spectrum of neurologic disease in HTLV-1 patients, including polyneuropathy, myopathy, neurogenic bladder, cognitive disorders, ALS-like (amyotrophic lateral sclerosis) episodes, meningeal syndromes and cranial neuropathy. The pathogenesis of the neurological manifestations of HTLV-1 infection is poorly understood 5 . The prevalence of overactive bladder syndrome, a form of neurogenic bladder, has been reported to be approximately 30% in HTLV-1 infected individuals without HAM/TSP in Brazil 6 . Some studies concluded that neurogenic bladder is a precursor of HAM/TSP since it represents spinal cord disease and often precedes the clinical manifestation of paraparesis by years 7 .
Our objective was to describe the neurological symptoms and signs in HTLV-1 infected patients without HAM/TSP, stratified on the presence or absence of overactive bladder.
MetHODS
This was a cross-sectional study of 102 patients followed at a cohort in the HTLV multidisciplinary clinic at the Bahia University Hospital (Hospital Universitário Professor Edgard Santos) from June 2004 to December 2010. The population of HTLV-1 infected patients was referred from blood banks, neurology and dermatology clinics in the city of Salvador. The patients enrolled in the study had serological confirmation of HTLV infection by ELISA (Cambridge Biotech Corp., Worcester, MA, USA) and confirmatory Western Blot (WB) analysis (HTLV blot 2.4, Genelab, Singapore).
Subjects were classified by presence or absence of overactive bladder according to the International Continence Society criteria 8 . Specifically, they were considered to have overactive bladder if reported urinary urgency with or without incontinence and usually with nocturia. Urodynamic study was done in patients with overactive bladder syndrome, confirming neurogenic bladder picture and urinary tract infection was ruled out by urine cultures.
The comparison group was composed of 51 randomly selected HTLV-1 patients from the cohort database who did not meet criteria for overactive bladder or HAM/TSP; these subjects were termed "asymptomatics".
exclusion criteria
Patients with HTLV-2 or indeterminate WB were excluded from analysis. We also excluded patients with HAM/TSP and comorbid infections (hepatitis B or C, syphilis, HIV and Chagas disease).
All subjects completed a questionnaire with epidemiological, clinical and laboratory data, and were examined by two neurologists (DT and AMS). The participant defined race and ethnicity in this study. Muscular strength was evaluated with the Medical Research Council criteria 9 as followed: 0=no muscular contraction; 1=little contraction; 2=active movement with no gravity; 3=active movement against gravity; 4=active movement against gravity and resistance; 5=normal. Arm and leg strength were evaluated in both sides in proximal and distal muscles. If the score was less than 4 in one muscle, the segment was considered weak for our analysis.
Reflexes were defined according to the Campbell score 10 in: 0=none; 1=present but diminished; 2=normal; 3=enhanced;
4=hyperactive, pathological and with clonus. The routinely evaluated reflexes were biceps, triceps, brachioradialis in both arms and patellar and ankle jerks in the legs. Any segment with a reflex graded 3 or 4 was considered abnormal. All subjects were also assessed by the assisting urologist (NC or PO) using a semi-structured interview, complete overall and urologic physical examination, and a standardized questionnaire (Urinary Distress Inventory -UDI 11 ) to determine the occurrence of urinary complaints. All men were assessed for erectile function using the International Index of Erectile Function (IEEF-5) 12 .
We also utilized two scales for evaluation of neurological symptoms: the Expanded Disability Status Scale (EDSS) 13 and the Osame Motor Disability Scale (OMDS) 14 . Proviral load was measured by real time PCR (Real-time TaqMan) in peripheral mononuclear blood cells (PBMCs) as described previously 15 . Data were analyzed using the STATA statistical software (version 11.1). Mean and standard deviations were calculated for continuous variables and proportions for categorical variables. Student's t-test was used to compare continuous variables. Chi-squared test and Fisher's exact test were used for categorical variables as appropriate. Univariate logistic regression was used to calculate odds ratios with 95% confidence intervals to describe the associations between overactive bladder and clinical characteristics. Similarly, multivariate logistic regression was used to adjust for potential confounders (i.e. age and gender). A p-value of less than 0.05 was used to determine statistical significance. 
reSUltS
We studied 102 HTLV-1 patients, divided into two groups: 51 patients with overactive bladder and 51 asymptomatic patients. Table 1 summarizes the demographic characteristics of the study population. The majority of patients were women, and female gender was associated with overactive bladder [OR (odds ratio) 3.46 (95%CI 1.35-8.88)]. The mean age of the overactive bladder group was higher than the asymptomatic group, though the difference was not statistically significant (46.4±1.9 vs. 42.3±1.7 years, respectively; p=0.11). Other demographic characteristics were similar between the two groups. The mean EDSS was 0.61±0.13 in overactive bladder group and 0 in asymptomatic group (p<0.01), and the OMDS was 0 in both groups by definition. 1.01-5.81). All of these symptoms, with the exception of dry mouth, remained statistically significant after adjustment for age and gender. In the objective neurological exam, no differences in arm and length strength or reflexes were noted between the groups. Proviral load was measured in 20 patients (10 in each group). Results for asymptomatics were 4.24±0.63 copies/10 6 PBMC, and for OB group 5.01±0.25 copies/10 6 PBMC. Statistical difference was found between the groups as showed in Figure. 
DiScUSSiON
In this cross-sectional study of HTLV-1 infected patients without HAM/TSP, we found a higher prevalence of neurological complaints in patients who met criteria for overactive bladder compared to those who did not. Specifically, patients with overactive bladder more commonly reported numbness and weakness of the arms and legs. Objective neurologic findings, however, did not differ between the two groups.
Several prior studies have evaluated neurological signs and symptoms in HTLV-1 patients without HAM/TSP without a specific focus on overactive bladder. In a prospective cohort study with average follow-up of over 10 years, Biswas and colleagues 16 compared groups of HTLV-1 and HTLV-2 infected subjects without HAM/TSP to seronegative controls and found a broad spectrum of neurologic symptoms and signs that were more prevalent among the HTLV infected subjects. The HTLV-1 group specifically had higher prevalence of leg weakness, impaired tandem gait, Babinski sign, impaired vibration sense and urinary incontinence 16 . Zunt et al. 17 found that HTLV-1-infected female commercial sex workers had greater values on quantitative spasticity assessment than seronegative controls despite having a similar prevalence of neurologic symptoms. Specifically, among the 32 HTLV-1 infected women, 13% complained of walking difficulty, 25% reported weakness, 16% bladder incontinence and 3% had abnormal reflexes.
Another study that evaluated 335 HTLV-1 patients without HAM/TSP found that 13.4% had symptoms and/or signs of peripheral neuropathy (hypoesthesia, burning sensations, paresthesia or hyperesthesia) 18 . In contrast, our study found a higher prevalence of sensory symptoms especially in the overactive bladder group, in which over half of subjects reported paresthesias in the hands or feet.
Caskey et al. 19 described clinical and neurological complaints in patients with HTLV-1 without HAM/TSP compared to health blood donors. In this study, HTLV-1 infected subjects 
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were more likely to report arm or leg weakness, hand or foot numbness, arthralgia, nocturia, erectile dysfunction, gingivitis, periodontitis and dry oral mucosa. In a subanalysis, HTLV-1 infected subjects with urological symptoms more commonly reported other neurological symptoms, whereas HTLV-1 negative controls with urinary symptoms were not more likely to report other symptoms. The pathogenesis of neurologic disease in HTLV-1 infection is not well understood, though higher HTLV-1 proviral loads are associated with HAM/TSP 20 and correlated with progression of motor dysfunction in this setting 21 . Of note, Silva and colleagues found that HTLV-1-infected individuals with neurological abnormalities other than HAM/TSP (including isolated neurogenic bladder) had significantly higher proviral loads compared to HTLV-1 asymptomatic individuals 22 . Longitudinal studies are needed to clarify the potential predictive value of proviral load in patients with overactive bladder with respect to future risk of HAM/TSP.
Our study has several noteworthy limitations, including its cross-sectional design and relatively small sample size. Clinicians were not blinded to whether subjects had overactive bladder syndrome, which may have introduced bias in the assessments. Lastly, the definition of overactive bladder was based on self-reported symptoms alone. Any misclassification of patient status, however, would have biased the study towards not finding differences between groups.
Taken together, our data and those of others suggest that HTLV-I infection is associated with a wide spectrum of neurological dysfunction and that HAM/TSP is only the "tip of the iceberg" 5 . In particular, patients with symptoms of overactive bladder tend to have more neurologic complaints and should be monitored carefully for progression of neurologic disease. Further longitudinal studies are needed to elucidate the natural history of neurological dysfunction in HTLV-1 patients with overactive bladder.
